Organic Process Research & Development 2006, 10, 1172−1177
Reaction Engineering of Benzaldehyde Lyase from Pseudomonas fluorescens
Catalyzing Enantioselective C-C Bond Formation
Thomas Stillger,†,| Martina Pohl,‡ Christian Wandrey,† and Andreas Liese§,*
Institute of Biotechnology, Research Centre Juelich, D-52425 Juelich, Germany, Institute of Molecular Enzyme
Technology, Heinrich Heine UniVersity of Duesseldorf, D-52426 Ju¨lich, Germany, and Institute of Technical Biocatalysis,
Hamburg UniVersity of Technology (TUHH), 21073 Hamburg, Germany
Abstract:
The reaction engineering of benzaldehyde lyase (BAL, E.C.
4.1.2.38) from Pseudomonas fluorescens catalyzing the enantio-
selective carboligation of benzaldehyde and acetaldehyde yield-
ing (R)-2-hydroxy-1-phenylpropanone (HPP) is presented. Based
on kinetic studies a continuous process is developed. The
developed bioreactor allows focusing the complex reaction
system on the production of HPP with simultaneous discrimina-
tion of the undesired benzoin formation. The application of a
continuous process in combination with membrane technology
enables high space time yields (1120 g L-1 d-1, ee > 99%) of
Figure 1. BAL-catalyzed carboligation.
the product as well as high total turnover numbers of the
biocatalyst (mol of product/mol of biocatalyst ) 188.000). A
kinetic model was developed to simulate the continuously
operated reactor and to determine optimal production condi-
the enzyme benzaldehyde lyase (BAL, E.C. 4.1.2.38) from
Pseudomonas fluorescens catalyzes the reversible formation
of 2-hydroxy ketones with high chemical and optical
yields.8-10 Chiral hydroxy ketones are versatile building
blocks in organic chemistry and widespread subunits in
biological active molecules.11 Therefore the valuable syn-
thetic potential of the ThDP-dependent enzymes might be
tions. The synthesis of (R)-(3-chlorophenyl)-2-hydroxy-1-pro-
panone (1214 g L-1 d-1, ee ) 99%) in the bioreactor demon-
strates a broad applicability of the presented reactor concept
for the production HPP derivatives.
used as a key step to introduce chirality into multistep
chemoenzymatic syntheses of pharmaceuticals, agrochemi-
cals, and pheromones.
Introduction
The crystal structure of BAL has just recently been
The catalytic asymmetric C-C bond formation is still a
challenge in organic catalysis.1 Classical methods in organic
chemistry, e.g., chiral thiazolium and triazolium catalysts,
usually afford anhydrous reaction media and the protection
of acidic functional groups.2-4 Thiamine-diphosphate
(ThDP)-dependent enzymes could be regarded as a biocata-
lytical pendent of thiazolium and triazolium catalyst.5 The
application of ThDP-dependent enzymes in organic synthesis
enables a convergent reaction pathway in combination with
mild aqueous reaction conditions and no need for protecting
group chemistry.6,7 Starting with achiral and cheap aldehydes
published.12 Detailed studies on the substrate spectra of BAL
have been described in the past 7 years.10,13-15 Aromatic as
well as aliphatic aldehydes are accepted by the enzyme
yielding either benzoins as a product of self-condensation
of the aromatic aldehyde or 2-hydroxy ketones derived by
carboligation of the aromatic and the aliphatic aldehyde
which we focus on in this study (Figure 1).
In this publication we present the reaction engineering
of BAL catalyzing the carboligation of benzaldehyde and
acetaldehyde yielding (R)-2-hydroxy-1-phenylpropanone ((R)-
HPP). In a previous paper we reported the development of
* To whom correspondence should be addressed. Fax: +49-40-42878-2127.
E-mail: liese@tuhh.de.
(8) Demir, A. S.; Pohl, M.; Janzen, E.; Mu¨ller, M. J. Chem. Soc., Perkin Trans.
1 2001, 633.
(9) Gonzales, B.; Merino, A.; Almeida, M.; Vicuna, R. Appl. Mircrobiol.
Biotechnol. 1986, 52, 1428.
(10) Gonzales, B.; Vicuna, R. J. Bacteriol. 1989, 171, 2401.
(11) Adam, W.; Lazarus, M.; Saha-Mo¨ller, C. R.; Schreier, P. Acc. Chem. Res.
1999, 32, 837.
(12) Mosbacher, T. G.; Mu¨ller, M.; Schulz, G. E. Fed. Eur. Biochem. Soc. 2005,
272, 6067.
(13) Demir, A. S.; Sesenoglu, O¨ .; Eren, E.; Hosrik, B.; Pohl, M.; Janzen, E.;
Kolter, D.; Feldmann, R.; Du¨nkelmann, P.; Mu¨ller, M. AdV. Synth. Catal.
2002, 344, 96.
(14) Du¨nkelmann, P.; Kolter, D.; Nitsche, A.; Demir, A. S.; Siegert, P.; Lingen,
B.; Baumann, M.; Pohl, M.; Mu¨ller, M. J. Am. Chem. Soc. 2002, 124, 12084.
(15) Demir, A. S.; Sesenoglu, O¨ .; Du¨nkelmann, P.; Mu¨ller, M. Org. Lett. 2003,
5, 2047.
† Research Centre Juelich.
‡ Heinrich Heine University of Duesseldorf.
§ Hamburg University of Technology (TUHH).
| Present address: Institute of Pharmaceutical Sciences, University of Freiburg,
Albertstrasse 25, D-79104 Freiburg, Germany.
(1) Faber, K.; Patel, R. N. Curr. Opin. Biotechnol. 2000, 11, 517.
(2) Enders, D.; Balensiefer, T. Acc. Chem. Res. 2004, 37, 534.
(3) Enders, D.; Breuer, K.; Teles, J. H. HelV. Chim. Acta 1996, 79, 1217.
(4) Enders, D.; Niemeier, O.; Balensiefer, T. Angew. Chem., Int. Ed. 2006, 45,
1463.
(5) Pohl, M.; Sprenger, G. A.; Mu¨ller, M. Curr. Opin. Biotechnol. 2004, 15,
335.
(6) Pohl, M.; Lingen, B.; Mu¨ller, M. Chem.sEur. J. 2002, 8, 5288.
(7) Liese, A.; Seelbach, K.; Wandrey, C. Industrial Biotransformations, 2nd
ed.; VCH-Wiley: Weinheim, 2006.
1172
•
Vol. 10, No. 6, 2006 / Organic Process Research & Development
10.1021/op0601316 CCC: $33.50 © 2006 American Chemical Society
Published on Web 11/04/2006